{"url_path":"/sec/anip/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000050-index.html","accession_number":"0001023024-26-000050","cik":"0001023024","ticker":"ANIP","issuer_name":"ANI PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000050-index.html","primary_entity_key":"0001023024","primary_entity_name":"ANI PHARMACEUTICALS INC"},"word_count":321,"has_tables":true,"body_markdown":"Item 5.    Other Information\n\nTrading Arrangements\n\nOur directors and executive officers may from time to time enter into plans or other arrangements for the purchase or sale of our common stock that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or may represent a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K).\n\nOn March 4, 2026, Chad Gassert, Senior Vice President, Head of Corporate Development and Strategy, adopted a Rule 10b5-1 trading plan. Mr. Gassert’s Rule 10b5-1 trading plan provides for a term commencing on June 3, 2026 and ending on January 31, 2027 for the sale of up to 135,000 shares of common stock of the Company.\n\nOn March 6, 2026, Stephen P. Carey, Senior Vice President, Finance and Chief Financial Officer, adopted a Rule 10b5-1 trading plan. Mr. Carey’s Rule 10b5-1 trading plan provides for a term commencing on June 5, 2026 and ending on June 8, 2027 for the sale of up to 44,138 shares of common stock of the Company, and 9,938 shares of common stock of the Company vested under outstanding stock options.\n\nOn March 9, 2026, Thomas J. Haughey, Chairman of the Board of Directors of the Company, adopted a Rule 10b5-1 trading plan. Mr. Haughey’s Rule 10b5-1 trading plan provides for a term commencing on June 8, 2026 and ending on June 15, 2027 for the sale of up to 10,000 shares of common stock of the Company.\n\nOn March 19, 2026, Muthusamy Shanmugam, Senior Vice President, Head of Research and Development and COO of New Jersey Operations of the Company, and a member of the Board of Directors of the Company, adopted a Rule 10b5-1 trading plan. Mr. Shanmugam’s Rule 10b5-1 trading plan provides for a term commencing on June 22, 2026 and ending on February 26, 2027 for the sale of up to 200,000 shares of common stock of the Company."}